Amneal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03168L1052

SecurityAMRX / Amneal Pharmaceuticals, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership5,690,586 shares
Latest Disclosed Value $ 70,722,579
Dimensional Fund Advisors Lp reports 1.45% increase in ownership of AMRX / Amneal Pharmaceuticals, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 5,690,586 shares of Amneal Pharmaceuticals, Inc. (US:AMRX) valued at $70,733,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 5,609,040 shares of Amneal Pharmaceuticals, Inc.. This represents a change in shares of 1.45% during the quarter. The current value of the position is $78,245,558 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,690,586 81,546 1.45 70,723 0.06 0.0032
2026-02-12 2025-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,609,040 177,906 3.28 70,681 30.02 0.0148
2025-11-12 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,431,134 133,764 2.53 54,361 26.84 0.0117
2025-08-12 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,297,370 194,214 3.81 42,857 0.22 0.0099
2025-05-13 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,103,156 111,454 2.23 42,761 8.17 0.0106
2025-02-13 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 4,991,702 278,653 5.91 39,531 0.82 0.0095
2024-11-07 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 4,713,049 429,121 10.02 39,208 44.12 0.0095
2024-08-09 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 4,283,928 641,405 17.61 27,205 23.25 0.0071
2024-05-10 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 3,642,523 819,910 29.05 22,074 28.83 0.0060
2024-02-07 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 2,822,613 847,801 42.93 17,134 105.57 0.0050
2023-11-09 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,974,812 776,702 64.83 8,335 124.66 0.0027
2023-08-09 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,198,110 -143,693 -10.71 3,710 99.03 0.0012
2023-05-12 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,341,803 112,635 9.16 1,865 93,100.00 0.0006
2023-02-09 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,229,168 -130,853 -9.62 2 -99.93 0.0007
2022-11-10 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,360,021 -449,771 -24.85 2,748 -52.26 0.0011
2022-08-12 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,809,792 170,470 10.40 5,756 -15.80 0.0021
2022-05-13 2022-03-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 1,639,322 124,301 8.20 6,836 -5.81 0.0021
2022-02-09 2021-12-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 1,515,021 172,629 12.86 7,258 1.23 0.0022
2021-11-12 2021-09-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 1,342,392 -42,041 -3.04 7,170 1.14 0.0023
2021-08-12 2021-06-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 1,384,433 466,726 50.86 7,089 14.78 0.0022
2021-05-14 2021-03-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 917,707 469,059 104.55 6,176 201.27 0.0020
2021-03-08 2020-12-31 13F/A-2 AMNEAL PHARMACEUTICALS COM 03168L105 448,648 152,832 51.66 2,050 78.57 0.0007
2021-02-11 2020-12-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 448,648 152,832 2,050 740.3510
2020-11-12 2020-09-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 295,816 98,354 49.81 1,148 22.13 0.0005
2020-08-13 2020-06-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 197,462 186,590 1,716.24 940 2,373.68 0.0004
2020-05-14 2020-03-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 10,872 -40,969 -79.03 38 -89.78 0.0000
2019-08-13 2019-06-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 51,841 -157,580 -75.25 372 -87.46 0.0001
2019-08-12 2019-03-31 13F/A-2 AMNEAL PHARMACEUTICALS COM 03168L105 209,421 -754,381 -78.27 2,967 -77.25 0.0012
2019-05-10 2019-03-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 209,421 -754,381 2,967
2019-02-26 2018-12-31 13F/A-1 AMNEAL PHARMACEUTICALS COM 03168L105 963,802 -670,950 -41.04 13,042 -64.05 0.0059
2019-02-13 2018-12-31 13F AMNEAL PHARMACEUTICALS COM 03168L105 963,802 13,042
2018-11-13 2018-09-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 1,634,752 -685,536 -29.55 36,274 -4.73 0.0138
2018-08-10 2018-06-30 13F AMNEAL PHARMACEUTICALS COM 03168L105 2,320,288 2,320,288 38,076 0.0152
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.